Document is current

Any future updates will be listed below

Quantitative assessment of BRAF V600 mutant circulating cell-free tumor DNA as a tool for therapeutic monitoring in metastatic melanoma patients treated with BRAF/MEK inhibitors

Crossref DOI link: https://doi.org/10.1186/s12967-016-0852-6

Published Online: 2016-04-19

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark